8/21/2026
Johnson & Johnson invests in Delix Therapeutics
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.
Topic archive
3 stories
8/21/2026
Investment in neuroplastogen company highlights growing interest in non-hallucinogenic psychedelics.
8/4/2026
Minimalist therapy model emphasizes patient-led recovery
7/24/2026
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.